Your Top 10 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial

Yelena Yuriy Janjigian, Jaffer A. Ajani, Markus Hermann Moehler, Lin Shen, Marcelo Garrido S, Carlos Gallardo and 20 more

Rank
5 of 493
Percentile
top 1.1%
Where
Journal of Clinical Oncology, 2024
Citations
256

From the 2024 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.